Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [


Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
12 2022
Historique:
revised: 23 11 2021
received: 08 09 2021
accepted: 12 12 2021
pubmed: 18 2 2022
medline: 3 1 2023
entrez: 17 2 2022
Statut: ppublish

Résumé

For 30 years synapse loss has been referred to as the major pathological correlate of cognitive impairment in Alzheimer's disease (AD). However, this statement is based on remarkably few patients studied by autopsy or biopsy. With the recent advent of synaptic vesicle glycoprotein 2A (SV2A) positron emission tomography (PET) imaging, we have begun to evaluate the consequences of synaptic alterations in vivo. We examined the relationship between synaptic density measured by [ Global synaptic density showed a significant positive association with global cognition and performance on five individual cognitive domains in participants with early AD. Synaptic density was a stronger predictor of cognitive performance than gray matter volume. These results confirm neuropathologic studies demonstrating a significant association between synaptic density and cognitive performance, and suggest that this correlation extends to the early stages of AD.

Identifiants

pubmed: 35174954
doi: 10.1002/alz.12582
pmc: PMC9381645
mid: NIHMS1766176
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2527-2536

Subventions

Organisme : National Center for Advancing Translational Science
ID : UL1TR000142
Organisme : NIA NIH HHS
ID : K23 AG057794
Pays : United States
Organisme : The National Institute on Aging
ID : P50AG047270
Organisme : The National Institute of Mental Health
ID : T32MH019961
Organisme : The National Institute on Aging
ID : R01AG052560
Organisme : The National Institute on Aging
ID : RF1AG057553
Organisme : The National Institute on Aging
ID : K23AG057784
Organisme : The National Institute on Aging
ID : P30AG021342
Organisme : The National Institute on Aging
ID : P30AG066508
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066508
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG062276
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG052560
Pays : United States
Organisme : The National Institute on Aging
ID : R01AG062276

Informations de copyright

© 2022 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

Références

Ann Neurol. 1991 Oct;30(4):572-80
pubmed: 1789684
Neurobiol Aging. 2018 Jan;61:207-214
pubmed: 29111487
Phys Med Biol. 2007 Mar 7;52(5):1505-26
pubmed: 17301468
Alzheimers Res Ther. 2021 Feb 5;13(1):35
pubmed: 33546722
J Cereb Blood Flow Metab. 2018 Nov;38(11):2041-2052
pubmed: 28792356
Ann Nucl Med. 2017 Aug;31(7):563-569
pubmed: 28639126
Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2150-4
pubmed: 7681585
Ann Neurol. 1990 May;27(5):457-64
pubmed: 2360787
Phys Med Biol. 2012 Nov 7;57(21):R119-59
pubmed: 23073343
Alzheimers Dement. 2020 Jul;16(7):974-982
pubmed: 32400950
Neuroimage. 2012 Aug 15;62(2):774-81
pubmed: 22248573
J Cereb Blood Flow Metab. 2002 Dec;22(12):1440-52
pubmed: 12468889
Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):390-402
pubmed: 31468182
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
Med Phys. 2013 Oct;40(10):102503
pubmed: 24089924
Alzheimers Dement. 2022 Dec;18(12):2527-2536
pubmed: 35174954
Alzheimers Res Ther. 2021 Jan 5;13(1):11
pubmed: 33402201
J Neuropathol Exp Neurol. 1992 Jul;51(4):404-14
pubmed: 1619440
Sci Transl Med. 2016 Jul 20;8(348):348ra96
pubmed: 27440727
Brain. 2014 Sep;137(Pt 9):2578-87
pubmed: 25012223
Mol Imaging Biol. 2020 Apr;22(2):444-452
pubmed: 31209780
Neurobiol Aging. 2006 Oct;27(10):1372-84
pubmed: 16289476
Neuroimage. 2004 Oct;23(2):724-38
pubmed: 15488422
Neurology. 2015 Aug 11;85(6):535-42
pubmed: 26180144
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
J Cereb Blood Flow Metab. 2020 Sep;40(9):1890-1901
pubmed: 31570041
JAMA Neurol. 2018 Oct 1;75(10):1215-1224
pubmed: 30014145
Alzheimers Dement. 2016 Aug;12(8):900-8
pubmed: 27243907

Auteurs

Adam P Mecca (AP)

Alzheimer's Disease Research Unit, Yale University School of Medicine, New Haven, Connecticut, USA.
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.

Ryan S O'Dell (RS)

Alzheimer's Disease Research Unit, Yale University School of Medicine, New Haven, Connecticut, USA.
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.

Emily S Sharp (ES)

Alzheimer's Disease Research Unit, Yale University School of Medicine, New Haven, Connecticut, USA.
Department of Neurology, Yale University School of Medicine, New Haven, Connecticut, USA.

Emmie R Banks (ER)

Alzheimer's Disease Research Unit, Yale University School of Medicine, New Haven, Connecticut, USA.
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.

Hugh H Bartlett (HH)

Alzheimer's Disease Research Unit, Yale University School of Medicine, New Haven, Connecticut, USA.
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.

Wenzhen Zhao (W)

Alzheimer's Disease Research Unit, Yale University School of Medicine, New Haven, Connecticut, USA.
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.

Sylwia Lipior (S)

Alzheimer's Disease Research Unit, Yale University School of Medicine, New Haven, Connecticut, USA.
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.

Nina G Diepenbrock (NG)

Alzheimer's Disease Research Unit, Yale University School of Medicine, New Haven, Connecticut, USA.
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.

Ming-Kai Chen (MK)

Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, Connecticut, USA.

Mika Naganawa (M)

Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, Connecticut, USA.

Takuya Toyonaga (T)

Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, Connecticut, USA.

Nabeel B Nabulsi (NB)

Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, Connecticut, USA.

Brent C Vander Wyk (BC)

Program on Aging, Yale University School of Medicine, New Haven, Connecticut, USA.

Amy F T Arnsten (AFT)

Alzheimer's Disease Research Unit, Yale University School of Medicine, New Haven, Connecticut, USA.
Department of Neuroscience, Yale University School of Medicine, New Haven, Connecticut, USA.

Yiyun Huang (Y)

Program on Aging, Yale University School of Medicine, New Haven, Connecticut, USA.

Richard E Carson (RE)

Program on Aging, Yale University School of Medicine, New Haven, Connecticut, USA.

Christopher H van Dyck (CH)

Alzheimer's Disease Research Unit, Yale University School of Medicine, New Haven, Connecticut, USA.
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Department of Neurology, Yale University School of Medicine, New Haven, Connecticut, USA.
Department of Neuroscience, Yale University School of Medicine, New Haven, Connecticut, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH